179 related articles for article (PubMed ID: 6541340)
1. A murine model for bladder cancer.
Murphy GP; Sandberg AA; Pontes JE; Ochi H; Yoshida M; Williams PD
Prog Clin Biol Res; 1984; 162A():177-200. PubMed ID: 6541340
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of chemotherapy in a murine model for bladder cancer.
Murphy GP; Pontes JE; Williams PD
Oncology; 1984; 41(3):195-9. PubMed ID: 6539460
[TBL] [Abstract][Full Text] [Related]
3. Intravesical and systemic chemotherapy of murine bladder cancer.
Soloway MS
Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041
[No Abstract] [Full Text] [Related]
4. Time- and concentration-dependent inhibition of the clonogenic growth of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder tumor cell lines by cis-diamminedichloroplatinum(II).
Niell HB; Wood CA; Mickey DD; Soloway MS
Cancer Res; 1982 Mar; 42(3):807-11. PubMed ID: 7199379
[TBL] [Abstract][Full Text] [Related]
5. The effect of platinum analogues and combination chemotherapy on murine bladder cancer.
Soloway MS; Cox CE
Trans Am Assoc Genitourin Surg; 1979; 71():8-13. PubMed ID: 545820
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
Soloway MS; Martino C; Hyatt C; Marrone JC
Natl Cancer Inst Monogr; 1978 Dec; (49):293-300. PubMed ID: 748783
[TBL] [Abstract][Full Text] [Related]
7. Prevention of bladder tumor formation in mice by a novel bone marrow-derived factor, reptimed.
Khandaker MH; Kadhim SA; Ichim TE; Howson-Jan K; Chin J; Singhal SK
Anticancer Res; 2000; 20(1A):183-9. PubMed ID: 10769653
[TBL] [Abstract][Full Text] [Related]
8. Chemoimmunotherapy of murine bladder cancer.
Stogdill BJ; Lamm DL; Livingston RB
Invest Urol; 1981 Nov; 19(3):179-81. PubMed ID: 7298287
[TBL] [Abstract][Full Text] [Related]
9. Protection from carcinogen-induced murine bladder carcinoma by interferons and an oral interferon-inducing pyrimidinone, bropirimine.
Borden EC; Sidky YA; Ertürk E; Wierenga W; Bryan GT
Cancer Res; 1990 Feb; 50(4):1071-4. PubMed ID: 2297754
[TBL] [Abstract][Full Text] [Related]
10. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
Hampel N; Persky L
Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
[TBL] [Abstract][Full Text] [Related]
11. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
12. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of chemotherapeutic agents against murine bladder metastasis.
Klaunig JE; Barut BA
J Urol; 1987 Dec; 138(6):1471-3. PubMed ID: 3682079
[TBL] [Abstract][Full Text] [Related]
14. Response of nude mouse-grown human urothelial cancer to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
Kyriazis AP; Yagoda A; Kyriazis AA; Fogh J
Cancer Res; 1985 May; 45(5):2012-5. PubMed ID: 3886128
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of polyribonucleotides for mouse transitional cell carcinoma enhanced by cyclophosphamide.
Borden EC; Sidky YA; Groveman DS; Bryan GT
Cancer Res; 1985 Jan; 45(1):45-50. PubMed ID: 3965150
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of bladder cancer.
Friedell GH; Jacobs JB; Nagy GK; Cohen SM
Am J Pathol; 1977 Nov; 89(2):431-42. PubMed ID: 920778
[TBL] [Abstract][Full Text] [Related]
17. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Wang CY; Hayashida S; Pamukcu AM; Bryan GT
Cancer Res; 1976 May; 36(5):1551-5. PubMed ID: 1268818
[TBL] [Abstract][Full Text] [Related]
18. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
Grossman HB; Sonda LP; Lesser ML
Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
[TBL] [Abstract][Full Text] [Related]
19. Development of an in vitro and in vivo epithelial tumor model for the study of invasion.
Pauli BU; Anderson SN; Memoli VA; Kuettner KE
Cancer Res; 1980 Dec; 40(12):4571-80. PubMed ID: 7438091
[TBL] [Abstract][Full Text] [Related]
20. [Chemosensitivity test for bladder cancer in a nude-mice experimental system].
Yamauchi T; Okada K; Yoshida O; Kawai T
Hinyokika Kiyo; 1986 Dec; 32(12):1949-58. PubMed ID: 3825832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
